Revenue and Profitability - Revenue for Q1 2023 was ¥158,582,024.06, a decrease of 53.81% compared to ¥343,330,779.81 in the same period last year[5] - Net loss attributable to shareholders was ¥38,073,427.83, representing a decline of 233.36% from a profit of ¥28,549,110.02 in Q1 2022[5] - Basic and diluted earnings per share were both -¥0.15, down 236.36% from ¥0.11 in Q1 2022[5] - Total operating revenue for Q1 2023 was CNY 158,582,024.06, a decrease of 53.8% compared to CNY 343,330,779.81 in the same period last year[24] - Net profit for Q1 2023 was a loss of CNY 37,953,613.94, compared to a profit of CNY 29,083,142.31 in Q1 2022[25] - Other comprehensive income after tax for Q1 2023 was a loss of CNY 13,168,968.33, compared to a gain of CNY 2,208,189.34 in the same period last year[25] Cash Flow and Investments - Operating cash flow improved by 51.97%, with a net cash flow of -¥55,246,942.08 compared to -¥115,016,641.99 in the previous year[5] - The net cash flow from operating activities was -$55.25 million, an improvement from -$115.02 million in the previous period, indicating a reduction in cash outflow[27] - Cash inflow from operating activities totaled $235.94 million, down from $261.50 million year-over-year[27] - Cash outflow from operating activities decreased to $291.19 million from $376.52 million, reflecting better cost management[27] - The net cash flow from investing activities was $5.86 million, a significant recovery from -$127.16 million in the previous period[28] - Cash inflow from investing activities increased to $110.93 million compared to $2.02 million in the prior period[28] - Cash outflow from investing activities decreased to $105.07 million from $129.18 million, showing a reduction in capital expenditures[28] - The net cash flow from financing activities was $4.87 million, down from $24.11 million in the previous period[28] - Cash inflow from financing activities was $59.98 million, a decrease from $168.60 million year-over-year[28] - The ending cash and cash equivalents balance was $784.85 million, down from $810.16 million in the previous period[28] - Cash received from tax refunds decreased by 68.50% to ¥8,539,222.02 compared to ¥27,104,391.27 in Q1 2022[12] Assets and Liabilities - Total assets decreased by 1.99% to ¥2,831,143,351.40 from ¥2,888,596,875.29 at the end of the previous year[5] - Total liabilities decreased to CNY 959,827,005.08 in Q1 2023 from CNY 967,189,497.90 in the previous quarter[22] - The company's equity attributable to shareholders was CNY 1,851,101,275.28, down from CNY 1,903,118,716.14 in the previous quarter[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,959[13] - The largest shareholder, Chen Zhenbiao, holds 31.43% of the shares, totaling 79,650,000 shares[13] - The company has repurchased a total of 4,602,535 shares, representing 1.8162% of the total share capital as of March 23, 2023[17] - The average repurchase price was 16.29 RMB per share, with a total expenditure of 74,989,514.25 RMB[17] - The company plans to use repurchased shares for employee stock ownership plans or equity incentive plans[15] - The total number of shares held by the top ten shareholders includes significant stakes from Chen Zhenbiao and Chen Zhenlu, who are related parties[14] - The company has extended the repurchase plan deadline to March 23, 2023, to complete the share buyback[16] Expenses - Total operating costs for Q1 2023 were CNY 199,201,090.84, down 33.2% from CNY 298,257,813.71 year-on-year[24] - Research and development expenses decreased by 33.93% to ¥4,074,786.20 from ¥6,167,050.17 in the same period last year[11] - Research and development expenses for Q1 2023 were CNY 4,074,786.20, a decrease of 33.9% from CNY 6,167,050.17 in Q1 2022[24] - The company reported a 19713.92% increase in financial expenses, amounting to ¥13,091,386.67, primarily due to exchange rate fluctuations and increased convertible bond interest expenses[11] Inventory and Receivables - Accounts receivable decreased from 179,665,679.14 RMB at the beginning of the year to 146,578,729.40 RMB[20] - Inventory increased slightly from 424,210,276.40 RMB to 431,625,823.80 RMB during the same period[20] - The company experienced a significant increase in contract liabilities, rising 3211.08% to ¥9,683,952.66 due to increased customer prepayments[9]

一、说明会类型 证券代码：300673 证券简称：佩蒂股份 公告编号：2023-027 债券代码：123133 债券简称：佩蒂转债 佩蒂动物营养科技股份有限公司 关于举行 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 2023年4月25日，佩蒂动物营养科技股份有限公司（以下简称公司）在巨潮资讯 网（http://www.cninfo.com.cn/）披露了《2022年年度报告》《2022年年度报告摘要》 《2023年第一季度报告》等相关公告。为便于广大投资者更深入、全面地了解公司发 展战略、生产经营等情况，公司定于2023年5月8日（星期一）15:00-17:00在在"价 值在线"（www.ir-online.cn）举办"佩蒂股份2022年度业绩说明会"。 二、出席会议的嘉宾 出席本次业绩说明会的嘉宾有：董事长兼总经理陈振标先生，董事、董事会秘书 兼财务总监唐照波先生，独立董事余飞涛女士，保荐机构安信证券股份有限公司保荐 代表人王耀先生。 三、投资者参与方式 为充分尊重投资者、提升交流的针对性，公司现就本次业绩说明会提前向投 ...

Group 1: Industry Overview - The pet industry has a long history of over a hundred years abroad, evolving through various stages to become stable and mature [2] - Key trends in the overseas market include the shift towards pet snacks as staple food and consumption upgrades, with pet snacks growing faster than the industry average [2] - In the domestic market, there is a rapid expansion in total market volume, with a noticeable trend towards high-quality development and consumption upgrades [2] Group 2: Company Strategy and Focus Areas - The company views its proprietary brand business as a strategic focus, with key projects for 2023 including transforming the "Jueyan" brand from a product-focused to a brand-focused approach [2] - The "Haoshijia" brand aims to enhance user experience, focusing on mid-to-high-end products, with its wet food becoming an online bestseller [2] - Investment in new media marketing resources is prioritized to improve product penetration and deepen consumer recognition and experience [2] Group 3: Production and Global Strategy - The company implements a "dual-wheel drive" development strategy, with global layout as a core competitive advantage [3] - Current production capacity includes factories in Wenzhou and Jiangsu (China), Vietnam, Cambodia, and New Zealand, focusing on various pet food products [3] - The company's vision is to become an excellent builder of a harmonious and healthy ecosystem for pets, with a mission to upgrade pet health standards globally [3] Group 4: Financial Goals and Market Expectations - The financial targets for proprietary brands are primarily assessed through revenue, with additional goals including average transaction value, repurchase rates, and growth in high-end users [3] - The domestic market's annual targets are set based on growth potential analysis for each business line, with quarterly reviews to track progress [3] - Expectations for the overseas market indicate stable growth, with normal operations in factories and logistics [3] Group 5: Product and Market Insights - The gross profit margin for proprietary brands varies significantly between online and offline channels, with online margins being notably higher [4] - The New Zealand factory specializes in high-meat content products, recognized globally for quality, leading to a premium for origin [4] - Offline sales primarily occur through B2B channels, with a focus on product display in retail stores [4]

Group 1: Company Overview - Petty Animal Nutrition Technology Co., Ltd. has established production bases both domestically and internationally, including locations in Wenzhou and Taizhou, China, and three factories in Vietnam, with additional bases in New Zealand and Cambodia under construction [1] - The main products from the Wenzhou base are animal skin chew toys, while the Taizhou base focuses on plant-based chew toys and nutritious meat snacks [1] Group 2: Product and Market Strategy - The primary market for the main grain products produced in New Zealand will be China, targeting both self-owned brands and overseas ODM sales [2] - The competitive advantages of the New Zealand grain factory include high-quality local raw materials, advanced production equipment, guaranteed quality control, and scientifically developed nutritional formulas [2] Group 3: Research and Development - In 2019, the company invested over 27 million yuan in R&D, collaborating with renowned universities and scientific teams to enhance product quality [2] - The company is currently focusing on expanding its domestic market, with a dedicated domestic market division established in 2018 [2] Group 4: Management and Performance Metrics - The management team is evaluated based on a comprehensive target-oriented assessment, with key performance indicators focused on revenue and profit [2]

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------|------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系活动类 | □ | 媒体采访 □业绩说明会 | | 别 | □新闻发布会 □路演活动 | | | | □ 投资者现场参观、交流 | | | | □ 其他 | 开源证券研究所大组总监/中小盘首席：任浪； 开源证券研究所农林牧渔首席分析师：陈雪丽； | | 投资者单位及姓名 | 开源证券研究所研究员：丁旺； | | | （排名不分先后） | 上海博观投资：张世栋 | 湖南轻盐创业投资管理有限公司投资经理：刘 ...

投资者关系活动记录表 | --- | --- | --- | |-----------------------|-------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | | □ 媒体采访 □业绩说明会 | | | 投资者关系活动类 | □新闻发布会 □路演活动 | | | 别 | □ 投资者现场参观、交流 | | | 投资者单位及姓名 | □ 其他 中信证券：彭家乐 中信证券资管：魏喆 睿远基金：黄云昊 中天国富证券：冯昕宜 中 ...